Molecular Mechanisms and Treatment of Neurological Diseases: Recent Advances and Future Trends
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 4049
Special Issue Editor
Interests: neurodegenerative diseases; dementia; Alzheimer's disease; frontotemporal lobe degeneration; stroke; drugs and treatments on brain diseases; stem cell therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurological diseases are characterized by progressive functional decline of the nervous system accompanied by structural, biochemical or electrical abnormalities in the brain, spinal cord and/or other nerves. Degeneration and death of neurons is the fundamental process responsible for the clinical manifestations of many different neurological disorders of aging. Age-related neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), stroke, and frontotemporal lobar dementia are highly associated with the increase in lifespan and display behavioral deficits in memory, cognition, problem solving, executive function, language, emotion, and related brain functions. Despite the increasing global burden of neurological disorders, to date, there is a lack of effective diagnostic and therapeutic stretagies. Since neurodegeneration is associated with various pathological processes, targeting multiple mechanisms underlying the neuroprotective effects such as preventing cell death and neuroinflammation should be employed. The alternative therapeutic approaches, including optical, electrical and magnetic stimulation therapies were also conferred for neurological disorders.
This Special Issue of Biomedicines attempts to investigate the novel pathogenetic mechanism involved in neurological diseases and focus on development of novel therapeutic strategies. Original articles and reviews are welcome for publication on the topic.
Prof. Dr. Kuen-Jer Tsai
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurological disorders
- neuromuscular diseases
- epilepsy
- peripheral neuropathy
- neurodegeneration
- neurodegenerative diseases
- dementia
- Alzheimer’s disease
- Parkinson’s disease
- frontotemporal lobar degeneration
- stroke
- brain injury
- neurogenesis
- neuroinflammation
- autophagy
- neuromodulation
- drug treatment
- cell therapy
